Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Nitrilase Hydrolysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106676140A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction for clopidogrel intermediates.
Patent CN101906447B reveals a biocatalytic route for 3,6-dichloropyrimidine-2-carboxylic acid. This method offers significant cost reduction in agrochemical manufacturing and enhanced supply chain reliability.
Patent CN104342463B reveals high-purity biocatalytic route. Enhances supply chain reliability and reduces manufacturing costs for gabapentin intermediates significantly for global buyers.
Patent CN101709323B reveals a novel biocatalytic coupling method for R-mandelic acid production, offering superior purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN102277322A details a novel enzymatic route for Iminodiacetic Acid (IDA) synthesis, offering significant waste reduction and milder reaction conditions compared to traditional chemical hydrolysis methods.
Novel biocatalytic method for R-mandelic acid production. High purity over 99 percent, cost-effective, scalable process for pharmaceutical supply chains.
Patent CN108715881B reveals a dual-enzyme route for pregabalin intermediates. Achieve 99.5% e.e. and simplified processing for cost-effective API manufacturing.
Patent CN107641622B reveals efficient enzymatic hydrolysis of terephthalonitrile, offering cost reduction in pharmaceutical intermediate manufacturing with high substrate tolerance.
Patent CN102277320B reveals enzymatic IDA synthesis reducing waste. Discover cost-effective, high-purity agrochemical intermediate solutions for glyphosate production.
Patent CN101701243B details a high-efficiency biocatalytic route for R-mandelic acid using Alcaligenes faecalis, offering superior purity and cost reduction in pharmaceutical intermediate manufacturing.